RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Carlos A. Paladini to Male

This is a "connection" page, showing publications Carlos A. Paladini has written about Male.
Connection Strength

0.374
  1. Otomo K, Perkins J, Kulkarni A, Stojanovic S, Roeper J, Paladini CA. In vivo patch-clamp recordings reveal distinct subthreshold signatures and threshold dynamics of midbrain dopamine neurons. Nat Commun. 2020 12 08; 11(1):6286.
    View in: PubMed
    Score: 0.050
  2. Gomez JA, Perkins JM, Beaudoin GM, Cook NB, Quraishi SA, Szoeke EA, Thangamani K, Tschumi CW, Wanat MJ, Maroof AM, Beckstead MJ, Rosenberg PA, Paladini CA. Ventral tegmental area astrocytes orchestrate avoidance and approach behavior. Nat Commun. 2019 03 29; 10(1):1455.
    View in: PubMed
    Score: 0.044
  3. Beaudoin GMJ, Gomez JA, Perkins J, Bland JL, Petko AK, Paladini CA. Cocaine Selectively Reorganizes Excitatory Inputs to Substantia Nigra Pars Compacta Dopamine Neurons. J Neurosci. 2018 01 31; 38(5):1151-1159.
    View in: PubMed
    Score: 0.041
  4. Simmons DV, Petko AK, Paladini CA. Differential expression of long-term potentiation among identified inhibitory inputs to dopamine neurons. J Neurophysiol. 2017 10 01; 118(4):1998-2008.
    View in: PubMed
    Score: 0.039
  5. Goertz RB, Wanat MJ, Gomez JA, Brown ZJ, Phillips PE, Paladini CA. Cocaine increases dopaminergic neuron and motor activity via midbrain a1 adrenergic signaling. Neuropsychopharmacology. 2015 Mar 13; 40(5):1151-62.
    View in: PubMed
    Score: 0.034
  6. Lobb CJ, Wilson CJ, Paladini CA. A dynamic role for GABA receptors on the firing pattern of midbrain dopaminergic neurons. J Neurophysiol. 2010 Jul; 104(1):403-13.
    View in: PubMed
    Score: 0.024
  7. Paladini CA, Mitchell JM, Williams JT, Mark GP. Cocaine self-administration selectively decreases noradrenergic regulation of metabotropic glutamate receptor-mediated inhibition in dopamine neurons. J Neurosci. 2004 Jun 02; 24(22):5209-15.
    View in: PubMed
    Score: 0.016
  8. Paladini CA, Williams JT. Noradrenergic inhibition of midbrain dopamine neurons. J Neurosci. 2004 May 12; 24(19):4568-75.
    View in: PubMed
    Score: 0.016
  9. Mencacci C. Efficacy and tolerability of switching to ziprasidone in italian patients with acute exacerbation of schizophrenia: an open-label trial. Pharmacopsychiatry. 2012 Sep; 45(6):236-40.
    View in: PubMed
    Score: 0.014
  10. Paladini CA, Fiorillo CD, Morikawa H, Williams JT. Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons. Nat Neurosci. 2001 Mar; 4(3):275-81.
    View in: PubMed
    Score: 0.013
  11. Porter-Stransky KA, Petko AK, Karne SL, Liles LC, Urs NM, Caron MG, Paladini CA, Weinshenker D. Loss of ?-arrestin2 in D2 cells alters neuronal excitability in the nucleus accumbens and behavioral responses to psychostimulants and opioids. Addict Biol. 2020 11; 25(6):e12823.
    View in: PubMed
    Score: 0.011
  12. Paladini CA, Tepper JM. GABA(A) and GABA(B) antagonists differentially affect the firing pattern of substantia nigra dopaminergic neurons in vivo. Synapse. 1999 Jun 01; 32(3):165-76.
    View in: PubMed
    Score: 0.011
  13. Paladini CA, Celada P, Tepper JM. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo. Neuroscience. 1999 Mar; 89(3):799-812.
    View in: PubMed
    Score: 0.011
  14. Wang HL, Zhang S, Qi J, Wang H, Cachope R, Mejias-Aponte CA, Gomez JA, Mateo-Semidey GE, Beaudoin GMJ, Paladini CA, Cheer JF, Morales M. Dorsal Raphe Dual Serotonin-Glutamate Neurons Drive Reward by Establishing Excitatory Synapses on VTA Mesoaccumbens Dopamine Neurons. Cell Rep. 2019 01 29; 26(5):1128-1142.e7.
    View in: PubMed
    Score: 0.011
  15. Frezzotti A, Galeazzi M, Paladini C, Tocchini M. Haemoglobinopathies in nonendemic areas in recent years. Clin Chem Lab Med. 2014 Feb; 52(2):e17-9.
    View in: PubMed
    Score: 0.008
  16. Branch SY, Goertz RB, Sharpe AL, Pierce J, Roy S, Ko D, Paladini CA, Beckstead MJ. Food restriction increases glutamate receptor-mediated burst firing of dopamine neurons. J Neurosci. 2013 Aug 21; 33(34):13861-72.
    View in: PubMed
    Score: 0.008
  17. Galeazzi M, Frezzotti A, Paladini C, Leoni P, Tocchini M. A case of monoclonal gammopathy of undetermined significance (MGUS): type IgD-lambda. Clin Chem Lab Med. 2013 Jun; 51(6):e123-5.
    View in: PubMed
    Score: 0.007
  18. Arencibia-Albite F, Paladini C, Williams JT, Jim?nez-Rivera CA. Noradrenergic modulation of the hyperpolarization-activated cation current (Ih) in dopamine neurons of the ventral tegmental area. Neuroscience. 2007 Oct 26; 149(2):303-14.
    View in: PubMed
    Score: 0.005
  19. Gambi F, Reale M, Iarlori C, Salone A, Toma L, Paladini C, De Luca G, Feliciani C, Salvatore M, Salerno RM, Theoharides TC, Conti P, Exton M, Gambi D. Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1 beta levels and expression in peripheral blood mononuclear cells. J Clin Psychopharmacol. 2004 Jun; 24(3):314-21.
    View in: PubMed
    Score: 0.004
  20. Celada P, Paladini CA, Tepper JM. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata. Neuroscience. 1999 Mar; 89(3):813-25.
    View in: PubMed
    Score: 0.003
  21. Bocola V, Trecco MD, Fabbrini G, Paladini C, Sollecito A, Martucci N. Antipanic effect of fluoxetine measured by CO2 challenge test. Biol Psychiatry. 1998 Apr 15; 43(8):612-5.
    View in: PubMed
    Score: 0.003
  22. Bocola V, Fabbrini G, Sollecito A, Paladini C, Martucci N. Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs. J Neurol Neurosurg Psychiatry. 1996 Feb; 60(2):213-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support